Suchergebnisse - "Liu, Shengwu"

PubPharm (44)

1

Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer

enthalten in: Cancer cell | 2024

von Tong, X. | Patel, A. | Kim, E. | +37

2

Adeno-to-squamous transition drives resistance to KRAS inhibition inLKB1mutant lung cancer

enthalten in: bioRxiv.org | 2023

von Tong, X. | Patel, A. | Kim, E. | +34

3

Mobocertinib in non-small cell lung cancer

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2022

von Liu, S. | Lowder, K.

4

Targeting HER2 Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib

enthalten in: Cancer research | 2021

von Han, H. | Li, S. | Chen, T. | +26

5

Mobocertinib (TAK-788) : A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer

enthalten in: Cancer discovery | 2021

von Gonzalvez, F. | Vincent, S. | Baker, T. | +23

CommentIn: Cancer Discov. 2021 Jul;11(7):1617-1619. - PMID 34284994

6

Acquired Resistance to KRASG12C Inhibition in Cancer

enthalten in: The New England journal of medicine | 2021

von Awad, M. | Liu, S. | Rybkin, I. | +34

CommentIn: N Engl J Med. 2021 Jun 24;384(25):2447-2449. - PMID 34161711

7

Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Ivanova, E. | Kuraguchi, M. | Xu, M. | +19

8

BET Bromodomain Inhibition Cooperates with PD-1 Blockade to Facilitate Antitumor Response in Kras-Mutant Non-Small Cell Lung Cancer

enthalten in: Cancer immunology research | 2018

von Adeegbe, D. | Liu, S. | Hattersley, M. | +18

9

Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Li, S. | Liu, S. | Deng, J. | +24

10

NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model

enthalten in: Cancer research | 2018

von Liu, Y. | Li, Y. | Liu, S. | +15

1
2
3
4
5
Nächster »
[5]